About this course

Learning Objectives

• recognize the type of medicine class of ketamine.
• consider the ongoing research into the brain regions and neurogenesis with KAP treatments, such as BDNF and VEGF growth factors with Ketamine.
• apply their understanding to clients readiness for KAP and, how to refer and formulate treatment plans to include KAP integration.
• identify both the clinical indications and contraindications for Ketamine-Assisted Psychotherapy (KAP), including a brief overview of recent research on its role in treating specific mental health conditions and considerations for client appropriateness.

Learning Levels

• Beginner and Intermediate, all levels are welcome

Target Audience

Course Instructor(s)

• 

  Karen Sprinkel, M.A., LMFT, SEP, CCTP

  Karen Sprinkel Ancelet is a psychotherapist, consultant, teacher, and author. Her unique East-West approach to healing trauma emerged over the seven years she lived in Asia. She has a very diverse background of experience, qualifications, and certifications gained over her 30 years of practicing psychotherapy. Her specialty is a combined trauma modality and certifications in EMDR, Brainspotting, Somatic Experiencing, Internal Family Systems (IFS, L3), HeartMath, Ketamine-Assisted Psychotherapy (KAP), and Psychedelic-Assisted Therapies (PAT).

  She is also trained in many other techniques, including but not limited to Flash Technique, Havening, EFT, ACT, Somatic Narrative and Resiliency, Ego-State, AEDP (Accelerated Experiential-Dynamic Psychotherapy), HeartMath and Vagas Toning. She is a Certified Clinical Trauma Professional and Continuing Education provider. She is licensed to practice therapy in California, Colorado, Oregon, Washington and Michigan. Karen is a member of multiple trauma treatment organizations. Karen has worked as a clinician with private clients for 30 years, while also working in mental health management in a variety of settings, including the following: as Director of Quality Assurance and Quality Improvement at East Bay Agency for Children, Manager of Clinical Administration at United Behavioral Health, and Director of Guidance and Counseling at Dulwich International College, Phuket, Thailand. Other direct clinical positions have included as a therapist at Clearwater Clinic and Assessment Services in Oakland, Mothers Against Drunk Driving, and Director of Victim Services at Families and Friends of Violent Crime Victims in Washington State.

Disclosure

References

• Bahji, A., Vazquez, G. H., & Zarate, C. A. (2021). Comparative efficacy of racemic ketamine and esketamine for depression: A systemic review and meta-analysis. Journal of Affective Disorders, 278, 542-55. https://doi.org/10.1016/j.jad.2020.09.071
• Bennett, R. (2020). Ethical guidelines for ketamine clinicians. Journal of Psychedelic Psychiatry, 2(4), 19-20. https://www.journalofpsychedelicpsychiatry.org
• Bennett, R. (2024). Educational pathways for psychedelic practitioners.Journal of Psychedelic Psychiatry, 6(2), 1-6. https://www.journalofpsychedelicpsychiatry.org/
• Breeksema, J. J., Niemeijer, A., Kuin, B., et al. (2022). Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study. Frontiers in Psychiatry, 13. https://doi.org/10.3389/ fpsyt.2022.948115
• Dames, S., Kryskow, P. & Watler, C. (2021). A cohort-based case report: The impact of ketamine-assisted psychotherapy embedded in a community of practice framework for healthcare providers with PTSD and depression. Frontiers in Psychiatry, 12. https://doi.org/10.3389/ fpsyt.2021.803279
• Sky, J. (2022). Psychedelic Medicine: A review of clinical research for a class of rapidly emerging behavioral health interventions. BrainFutures
• Sprinkel Ancelet, Karen, (2023). A New Paradigm for Healing Trauma in the Mind, Body and Spirit and Moving Beyond it. Amazon: The Thriving Self. Independent Publisher.
• Taraku, B., Loureiro, J. R., Sahib, A. K., et al (2024). Modulation of habenular and nucleus accumbens functional connectivity by ketamine in major depression. Brain and behavior, 14(6), e3511.
• van der Kolk, B. (2014). The Body Keeps the Score: Brain, Mind and Body in the Healing of Trauma. New York City, NY: Penguin Books.
• Wolfson, P. & Hartelius, G. (2016). Ketamine Papers. Multidisciplinary Association for Psychedelic Studies.
• Yeung A., Sapirstein G., Crain L.D., Cramer M.A., Forcen F.E. (2023). Pharmacotherapy and ketamine assisted psychotherapy for treatment-resistant depression: A patient with lifelong self￾doubt and self-criticism.